Glenmark Pharma is up almost 2.3% at Rs.506, with an intra day high and low at Rs.508.35 and Rs.492.70 respectively. Volumes are reasonable at 21,000 shares.

The stock is up on news that the company has received the final approval from the US health regulator for its generic Ointment- Desoximetasone. This ointment is used for relief from inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. The company will commence shipping of the product with immediate effect.